Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Twist Bioscience
TWST
$7.25B
| $1.39M | ﹤0.01% |
30,583
+7,956
| +35% | +$285K |
|
2427
Alamo Group
ALG
$2.05B
| $1.39M | ﹤0.01% |
13,491
+907
| +7% | +$87K |
|
|
CSGS
2428
DELISTED
CSG Systems International
CSGS
| $1.39M | ﹤0.01% |
33,471
-5,833
| -15% | -$267K |
|
2429
CALL
ArcelorMittal
MT
$55.3B
| $1.39M | ﹤0.01% |
129,100
-203,700
| -61% | -$2.05M |
|
|
SCS
2430
DELISTED
Steelcase
SCS
| $1.39M | ﹤0.01% |
114,883
+30,261
| +36% | +$331K |
|
|
TPTX
2431
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.38M | ﹤0.01% |
21,419
+7,040
| +49% | +$406K |
|
|
VGR
2432
DELISTED
Vector Group Ltd.
VGR
| $1.38M | ﹤0.01% |
193,817
+50,334
| +35% | +$385K |
|
2433
CEL-SCI Corp
CVM
$30.1M
| $1.38M | ﹤0.01% |
3,077
+2,710
| +738% | +$1.11M |
|
2434
Edgewell Personal Care
EPC
$1.31B
| $1.38M | ﹤0.01% |
44,178
+14,622
| +49% | +$410K |
|
|
TERP
2435
DELISTED
TerraForm Power, Inc
TERP
| $1.37M | ﹤0.01% |
74,323
+21,961
| +42% | +$389K |
|
2436
GoPro
GPRO
$126M
| $1.37M | ﹤0.01% |
287,992
-105,480
| -27% | -$400K |
|
2437
Teck Resources
TECK
$32.6B
| $1.37M | ﹤0.01% |
131,343
+73,698
| +128% | +$677K |
|
2438
CALL
RH
RH
$3.71B
| $1.37M | ﹤0.01% |
5,500
-58,500
| -91% | -$10.6M |
|
2439
PUT
Kinder Morgan
KMI
$68.7B
| $1.37M | ﹤0.01% |
90,200
-154,200
| -63% | -$2.34M |
|
|
VRE
2440
DELISTED
Veris Residential
VRE
| $1.37M | ﹤0.01% |
89,519
+11,062
| +14% | +$172K |
|
|
IMLP
2441
DELISTED
iPath S&P MLP ETN
IMLP
| $1.37M | ﹤0.01% |
150,000
| – | – |
|
|
JWN
2442
PUT
DELISTED
Nordstrom
JWN
| $1.37M | ﹤0.01% |
88,200
-130,000
| -60% | -$2.29M |
|
2443
AutoNation
AN
$6.92B
| $1.36M | ﹤0.01% |
36,297
-47,835
| -57% | -$1.73M |
|
2444
Karyopharm Therapeutics
KPTI
$48M
| $1.36M | ﹤0.01% |
4,801
+805
| +20% | +$238K |
|
|
ARI
2445
Apollo Commercial Real Estate
ARI
$885M
| $1.36M | ﹤0.01% |
138,990
+16,435
| +13% | +$139K |
|
2446
Gerdau
GGB
$9.7B
| $1.36M | ﹤0.01% |
579,797
-73,150
| -11% | -$139K |
|
|
LKFT
2447
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $1.36M | ﹤0.01% |
+6,900
| New | +$1.43M |
|
2448
Wintrust Financial
WTFC
$10.7B
| $1.36M | ﹤0.01% |
31,177
-127,133
| -80% | -$5.08M |
|
|
MDRX
2449
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.36M | ﹤0.01% |
201,096
+129,425
| +181% | +$839K |
|
|
CLVS
2450
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.36M | ﹤0.01% |
201,700
-200,600
| -50% | -$1.52M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.